Seeking Alpha

  Intercept Pharmaceuticals - NASDAQ

11/25/2014, 6:26 PM ET
  • Prohost Biotech | Send Message 12 Jan

    Intercept Liver Drug Is A Game Changer For The Biotech Industry $ICPT
      ICPT vs. ETF Alternatives
      Company Description
      Intercept Pharmaceuticals Inc is a development stage, Biopharmaceutical Company engaged in the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States